State-run pharmaceutical firm Bio Farma will begin phase three of clinical trials on humans this week - Reuters
JAKARTA (Reuters): Indonesia will have capacity to produce 250 million doses a year of a coronavirus vaccine by the end of 2020 pending trials on humans, a minister said on Tuesday (Aug 4), as the country seeks to halt a wave of infections that has shown no signs of slowing down.
Indonesia has confirmed 115,056 cases of Covid-19 and 5,388 deaths since its first infections in March. It has been reporting more than 1,000 new cases on most days since the start of June.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
